ALA 1.61% 15.3¢ arovella therapeutics limited

Sudoc, page-29

  1. CBD
    978 Posts.
    lightbulb Created with Sketch. 381
    Margaret I fear buckland carries more weight than you in his arguments.

    The biggest single problem has been who is there to keep Steve accountable for his performance. We have had only one independent director untill recent times so our CEO was keeping an eye on himself.

    Things need to change very quickly otherwise we will see a consolidation which will see shareholder capital destroyed even further.

    It is hard to support the current Boards stance toward shareholders and I fear many of the mammoth number of shares feel as I do.

    I think Paul Hopper needs to take control as clearly he is currently floundering which could reptesent the biggest threat to Suda yet.

    To put it another way, credibility with Steve is gone and Paul rightly or wrongly is starting to look weak.

    Beginning to regret yet again supporting Suda in their CR.

    The communication alone is disgraceful and that sits right at Paul Hoppets feet.

    Some things it would seem do not change.

    Clyde


 
watchlist Created with Sketch. Add ALA (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.